Haemostatic factors and ischaemic heart disease. The Caerphilly study.
Tóm tắt
Từ khóa
Tài liệu tham khảo
Heler RF, Chinn S, Tunstall Pedoe HD, Rose G. How weil can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J 1984; 288: 1409-11.
Meade TM, Chakrabarti R, Haine AP, North WRS, Stirling Y, Thompson SG. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; i: 1050-4.
Wilhelmsen L, Svardsudd K, Korsan-Benten K, Lars son B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N EnglJ Med 1984; 311: 501-5.
Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N EngII Med 1984; 310: 1137-40.
Rose GA, Blackburn H. Cardiovascular suney methods. Geneva: WHO, 1968.
Yarnell JWG, Milbank J, Walker CL, Fehily AM, Hayes TM. Detminants of high density lipoprotein and total cholesterol in women. J Epidemiol Co_nnu Heakh 1982; 36: 167-71.
Wright BM, Dore CF. A random-zero sphygmomanometer. Lancet 1970; i: 337-8.
Thorp JM, HorsfaUl GB, Stone MC. A new red-sensitive micronephedometer. Medical and Biological Enineering 1967; 5: 51-6.
Clauss A. Gerrinnungephysiologische Sclmethode sur Bestung des Fibrinogens. Acta Haematol (Basel) 1957; 17: 237-46.
Harkness J. The viscosity of human blood plasma; its measurement in health and diss. Bior*eoo 1971; 8: 171-93.
O'Brien JR, Ethrington M, Jamieson S, Lawford P, Sussex J, Lincoln SV. Heparin neuraliing activity test in the diagnosis of acute myocardial infarction. J CGin Pathd 1975; 28: 975-9.
Giddings JC, Peake IR. Principles of immunoassays of bacnostatic components. In: Bloom AL, Thomas DP, eds. Haemostasis and thombosis. Edinburgh: Churchill Livingstone, 1981: 252-67.
Baker IA, Easdtam R, Elwood PC, Etherington M, O'Brien JR, Sweetnam PM. Haemostatic factors associated with isc.aic heart disease in men aged 45 to 64 years: The Speedwell Study. BrHeartj 1982; 47: 490-4.
O'Brien JR, Etherington MD. Coronary heart disease, fibrinogen, and plasma heparin neutralising activity [Letter]. Lancet 1981; i: 495-6.
Brozovic M. Physiological mechanisms in coagulation and fibrinolysis. Br Med BuU 1977; 33: 2314.
Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y. Charistics affecdng fibrinolytic activity and plasma fibrinogen concentrations. BrMedJ 1979; i: 153-6.
Yarnel JWG, Fehily AM, Milbank J, Kubicki AJ, Eastham R, Hayes TH. Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales. J Epidemiol Commun_y Health 1983; 37: 137-40.
Reid DD, Hamilton PJS, McCartney P, Rose G, Jarrett RJ, Keen H. Smoking and other risk factors for coronary heart-disease in British civil servants. Lancet 1976; ii: 979-84.
Wright IS, Fredrickson DT. Report of Inter-Society Commission for Heart Disease Resources. Primary prevention of the atherosclerotic diseases. Circulation 1970; 42: A55-A94.
Armitage P. Statisticl methods in medical research. Oxford: Blackwell, 1971: 315.
Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engi J Med 1974; 290: 1275-8.
Zalokar JB, Richard JL, Claude JR. Leukocyte count, smoking and myocardial infarction. N EnglJ Med 1981; 304: 465-8.
Prentice RL, Szatrowski TP, Fujikura T, Kato H, Mason MW, Hamilton HH. Leukocyte counts and coronary heart disease in a Japanese cohort. AmJ Epidemiol 1982; 116: 496-509.
Prentice RL, Szatrowski TP, Kato H, Mason MW. Leukocyte counts and cerebrovascular disease.J Chronic Dis 1982; 35: 703-14.
Jacob HS, Hmmeschmidt DR. Complement-induced granulocyte ggregtion.JAMA 1981; 245: 2013-7.
Mitchinson MJ. Macphages, oxidised lipids and atherosderosis. Med Hypotses 1983; 12: 1714.